Quite trueregarding the respective revenue growth rates.
But then againPolonovo with a market cap over $1.6b is valued at around 80 x revenue, whereas Aroa with a market cap of $225.0m is currently valued at around 9 x revenue.
IMO Aroa wasconservatively priced at the ipo and a future valuation of 20 x revenue, (marketcap = $500.0m) in the near term is not out of the question. Subject to the impacts of covid19 on revenue.
- Forums
- IPOs
- Aroa Biosurgery IPO
Aroa Biosurgery IPO, page-49
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online